Document is current

Article History

Received: 8 January 2025

Accepted: 5 February 2025

First Online: 13 March 2025

Declarations

:

: Allen Hu received grants/contracts from 4D Molecular Therapeutics, AbbVie, Acelyrin, Alexion, Alimera Sciences, Annexin Pharmaceuticals, Annexon Biosciences, Apellis, Ashvattha Therapeutics, Aviceda Therapeutics, Bayer, Boehringer Ingelheim, Chengdu Kanghong, Clearside Biomedical, Cognition Therapeutics, Curacle, EyeBio, EyePoint Pharmaceuticals, Genentech, Graybug Vision, Henlius, Ionis, Iveric Bio, Janssen, Kodiak Sciences, LMRI, LumiThera, Lupin, Neurotech, Novartis, Ocular Therapeutix, Oculis, Ocuphire Pharma, Ophthotech, Opthea, Outlook Therapeutics, Oxurion, Regeneron, REGENXBIO, Rezolute, Roche, Sandoz, Smilebiotek Zhuhai Limited, Stealth BioTherapeutics, and UNITY; received consulting fees from Annexon Biosciences, Apellis, Bayer, Clearside Biomedical, Genentech, Janssen, Oculis, Outlook Therapeutics, Regeneron, Roche, and Stealth BioTherapeutics; participated in speakers bureaus for Apellis, Genentech, and Iveric Bio; and participated in advisory/data safety monitoring boards for Clearside Biomedical. Rachel E. Teneralli is an employee of Johnson & Johnson. Jessica Ackert is a former employee of Johnson & Johnson and is currently an employee at Sanofi. Rachelle Rodriguez is a former employee of Johnson & Johnson and is currently an employee at Star Epidemiology LLC. Alyshah Abdul Sultan is a former employee of Johnson & Johnson and is currently an employee at Sanofi. Colleen Garey is an employee of Panalgo, which received funding from Johnson & Johnson for this analysis. Rose Ong is an employee of Actelion Pharmaceuticals, Ltd., a Janssen Pharmaceutical Company of Johnson & Johnson.

: This study was based on de-identified data collected from three US health care claims databases and did not include human participants; as such, this analysis was exempt from institutional review board oversight and informed consent was not required or obtained.